Agios Pharmaceuticals Inc. buy Bank of America Co.
Start price
22.07.25
/
50%
€33.80
Target price
22.07.26
€43.63
Performance (%)
-30.77%
Price
12.12.25
€23.40
Summary
This prediction is currently active. Massive losses of -30.77% have been the result for the BUY prediction by Bank_of_America_Co_. This prediction currently runs until 22.07.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Agios Pharmaceuticals Inc. | -2.500% | -2.500% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target lowered by analysts at Bank of America Corporation from $52.00 to $51.00. They now have a "buy" rating on the stock.
Ratings data for AGIO provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€20.00
20.11.25
20.11.25
€27.77
20.11.26
20.11.26
17.00%
12.12.25
12.12.25
